Medical News

RSS

TearLab's Osmolarity test made available at point-of-care

TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.

11 Jan 2011

Geisinger implements NextGate's patient indexing software

NextGate, a leader in the IT indexing field, today announced that Geisinger Health System, widely recognized for its advanced electronic health record (EHR) and execution of innovative care models, is implementing NextGate's patient indexing software. The software will enhance the coordination of patient data across the health system and enable care providers to access patients' most up-to-date clinical information regardless of location.

11 Jan 2011

VIPdesk becomes wholly-owned subsidiary of International SOS

International SOS, the world's leading integrated medical and security assistance and concierge services company, and VIPdesk, the North American provider of industry-leading concierge services, customer care and loyalty programs, announced today the joining of forces to bring together the first truly integrated, global concierge and customer care service delivery platform.

11 Jan 2011

Novelda announces CMOS Impulse Radar Transceiver designed for ETSI and FCC compliance

Novelda AS announced today a CMOS Impulse Radar Transceiver designed for ETSI and FCC compliance within the 6.0GHz - 8.5GHz UWB-mask.

11 Jan 2011

First Edition: January 11, 2011

Today's headlines include reports about how a recent high court ruling may offer clues as to how the Supreme Court will view a key aspect of the health overhaul law.

11 Jan 2011

Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK

Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).

11 Jan 2011

EffRx moves to Switzerland

Former EffRx, Inc., Jupiter, FL, USA is now EffRx Pharmaceuticals SA, Biopôle, Route de la Corniche 4, Epalinges/Lausanne, Switzerland. The move took place on September 18, 2010 through a share exchange agreement.

11 Jan 2011

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.

11 Jan 2011

Cyclacel opens enrollment of sapacitabine Phase 3 trial for AML

Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.

11 Jan 2011

DynaVox Mayer-Johnson announces Boardmaker Player for Windows

DynaVox Mayer-Johnson, the leading provider of speech generating devices and symbol-adapted special education software used to assist individuals in overcoming speech, language and learning challenges, today announced Boardmaker Player for Windows.

11 Jan 2011

Group health insurance policies help attract high calibre employees

Group health insurance policies are an excellent means of attracting high calibre employees to your business. That's according to advisers from Health Insurance Solutions.

11 Jan 2011

California's DWC releases new medical bill regulations for public comment

New California electronic medical billing regulations and revised paper medical billing requirements were released January 6th for public comment by California's Division of Workers Compensation (DWC). The regulations, part of the Division's 12-point plan to help control medical costs in California's workers' compensation system, will be signed into law in approximately 60 days.

11 Jan 2011

HITRUST designates PwC as a Common Security Framework Assessor

PwC US announced today that the Health Information Trust Alliance (HITRUST) has designated the firm a Common Security Framework (CSF) Assessor, qualified to evaluate and certify security standards of CSF-related services.

11 Jan 2011

Swedes are consuming less alcohol

Despite the fact that the Swedish Alcohol Retail Monopoly's sales are rising and statistics from Statistics Sweden indicate that we drink more and more alcohol, the trend is going in the opposite direction - Swedes' alcohol consumption is falling. This emerges from the Consumption Report 2010 (Konsumtionsrapporten 2010) published by the Centre for Consumer Science at the University of Gothenburg.

11 Jan 2011

Cleveland Clinic and MedStar Health collaborate to create Innovation Alliance

Cleveland Clinic and MedStar Health have agreed to create an Innovation Alliance to benefit patients through collaborative innovation projects, research, clinical investigation, and commercialization application.

11 Jan 2011

Lilly and Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Eli Lilly and Company and Boehringer Ingelheim today announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development.

11 Jan 2011

Qui Tam case against NeoGenomics dismissed with prejudice

NeoGenomics, Inc. announced today that it has been notified that the Qui Tam complaint filed against it and several other healthcare companies in 2009 has been voluntarily dismissed with prejudice by the relator in the case. As a result, no further action will be taken against NeoGenomics in this matter.

11 Jan 2011

Mithridion secures commitments of $1.25 million in new funding

Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.

11 Jan 2011

Tri-Valley Medical Group physicians discuss issues impacting roll-out of health care reform

Local physicians from Tri-Valley Medical Group recently spent a week in Washington D.C. to discuss the fundamental issues impacting the roll-out of health care reform - and came away with a new appreciation of its challenges.

11 Jan 2011

Mechanism for binding oxygen to metalloporphyrins seen on a molecular level

The mechanism for binding oxygen to metalloporphyrins is a vital process for oxygen-breathing organisms. Understanding how small gas molecules are chemically bound to the metal complex is also important in catalysis or the implementation of chemical sensors. When investigating these binding mechanisms, scientists use porphyrin rings with a central cobalt or iron atom. They coat a copper or silver support surface with these substances.

11 Jan 2011